Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/12/11 13:15
2014/12/11 13:15
6d
GlaxoSmithKline Seeks Variation on OK for Ambrisentan LONDON – GlaxoSmithKline PLC said Thursday that it has submitted an application to the European Medicines Agency to widen the uses for which its...
2014/12/11 13:15
2014/12/11 13:15
Latest videos
2014/12/11 12:56
2014/12/11 12:56
6d
Overnight Media Digest * Starboard Value LP has built a roughly 6 percent stake in Staples Inc and increased its position in Office Depot Inc to about 10 percent, according to people familiar with...
2014/12/11 09:35
2014/12/11 09:35
6d
FINANCIAL MARKETS Asia shares drop as oil reinforces growth jitters TOKYO (AP) Asian stock markets slid again Thursday as falling oil prices reinforced jitters about a sluggish global economy. The...
2014/12/11 06:03
2014/12/11 06:03
6d
HAVERFORD, Pa. (AP) — Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences Inc. over the pricing of its hepatitis C drug. Sovaldi is a highly effective pill treatment...
2014/12/09 15:12
2014/12/09 15:12
8d
... HEA BIO MTC PHA -- WITH PHOTO -- TO HEALTH, MEDICAL, AND NATIONAL EDITORS: Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council WASHINGTON, Dec. 9, 2014...
2014/12/05 18:22
2014/12/05 18:22
12d
Follow @BretKenwell TheStreet Ratings team rates Gilead Sciences Inc as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation: "We rate GILEAD SCIENCES...
2014/12/01 14:08
2014/12/01 14:08
16d
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has licensed the non-exclusive rights...
2014/11/26 12:45
2014/11/26 12:45
21d
Steve Miller is waging war on high- priced medicine, guiding decisions to ban drugs from the health plans of millions of Americans and sending companies reeling in a $270 billion market. He and his...
2014/11/24 08:55
2014/11/24 08:55
23d
The medicine Elizabeth “Lizzy” West of Arkansas County needs to treat her cystic fibrosis will cost about $300,000 a year for the rest of her life. West and two other Arkansas Medicaid beneficiaries...
2014/11/19 03:17
2014/11/19 03:17
28d
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (NASDAQ: GILD), hat heute bekannt gegeben, dass es von der Europäischen Kommission die Zulassung für Harvoni®...
2014/11/19 02:17
2014/11/19 02:17
28d
Europese Commissie verleent vergunning voor het in de handel brengen voor Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), het eerste enkel-tabletregime voor de behandeling van patiënten met chronische...
2014/11/18 21:27
2014/11/18 21:27
28d
Nov. 18 (Bloomberg) -- It costs drugmakers $2.56 billion to bring a new medicine to market, on average, more than double the price of 11 years ago, according to a study released today. The higher...
2014/11/18 18:49
2014/11/18 18:49
29d
This is the second installment in a four-part series. LOS ANGELES (MarketWatch) -- Look around the health-care world, and the almighty dollar can rear its head just about anywhere. It’s often seen...
2014/11/17 12:13
2014/11/17 12:13
30d
Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than...
2014/11/14 23:48
2014/11/14 23:48
m
Janus Capital Group, Inc. (JNS), formerly one of the largest asset management firms in the world and now hoping for resurgence with the signing of PIMCO founder Bill Gross, sells multiple mutual funds...
2014/12/11 13:15
2014/12/11 13:15
Latest from Twitter